What Researchers Did
Researchers retrospectively analyzed the clinical data of 42 nasopharyngeal carcinoma patients who developed sudden deafness after receiving radiotherapy combined with chemotherapy.
What They Found
Most patients experienced severe (30 cases) or profound (6 cases) deafness, with 33 cases showing high-tone frequency hearing loss. Despite medical and hyperbaric oxygen therapy, only 13 out of 42 patients (30.95%) showed some recovery (2 cured, 2 excellent, 9 partial), while 29 showed no response.
What This Means for Canadian Patients
Canadian patients undergoing radiotherapy and chemotherapy for nasopharyngeal carcinoma should be aware of the potential for sudden, severe hearing loss. Current treatments for this type of hearing loss may have limited effectiveness, highlighting the need for early monitoring and potentially preventative strategies.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
The retrospective design and small sample size of 42 patients limit the generalizability of these findings.